"Pentazocine" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The first mixed agonist-antagonist analgesic to be marketed. It is an agonist at the kappa and sigma opioid receptors and has a weak antagonist action at the mu receptor. (From AMA Drug Evaluations Annual, 1991, p97)
| Descriptor ID |
D010423
|
| MeSH Number(s) |
D03.132.577.249.106.700 D04.615.723.795.106.700
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Pentazocine".
Below are MeSH descriptors whose meaning is more specific than "Pentazocine".
This graph shows the total number of publications written about "Pentazocine" by people in this website by year, and whether "Pentazocine" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1998 | 1 | 1 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Pentazocine" by people in Profiles.
-
Comparing the subjective, psychomotor and physiological effects of intravenous pentazocine and morphine in normal volunteers. J Pharmacol Exp Ther. 1998 Sep; 286(3):1197-207.
-
[Clinical evaluation of Azasetron Hydrochloride: a new selective 5-HT3 receptor antagonist--antiemetic profile and plasma concentration in transcatheter arterial chemoembolization using CDDP for unresectable hepatocellular carcinoma]. Gan To Kagaku Ryoho. 1998 Jul; 25(8):1197-202.
-
Pentazocine and tripelennamine abuse: T's and Blues. Psychiatr Med. 1985; 3(3):219-31.
-
Accelerated development of pulmonary complications due to illicit intravenous use of pentazocine and tripelennamine. Am J Med. 1984 Apr; 76(4):617-22.